C urrently, Ozempic is only approved to treat type 2 diabetes. But in recent years, the semaglutide injection has become a ...

HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm.

Federal spending cuts are putting billions of dollars in medical research, including studies on cancer, heart disease and ...

But the shingles studies published in 2024, along with a host of new papers, add weight to an alternative decades-old ...

Many trials exclude certain groups, and do so deliberately—children, for example, or people with physical or learning ...

While researchers continue to work on a full cure for Alzheimer's disease, they're finding treatments that can help manage ...

There has been progress. The latest Alzheimer’s drug appears to tackle the characteristic features of the disease in the ...

A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

A new Northwestern Medicine study publishing in Nature Medicine suggests a promising alternative to previous attempts to ...

Nonsteroidal anti-inflammatory drug use for over 2 years was associated with a lower risk for dementia, especially ...

TAKING a cheap over-the-counter medication could lower your risk of dementia by 12 per cent, a study suggests. Dutch ...

Novo Nordisk is a great pick to buy with the stock near its 52-week low. Vertex Pharmaceuticals is helping patients and ...